Global Immunoturbidimetry Reagents Market, By Indication (Kidney Function Test, Diabetes, High Blood Pressure, IVD Test), Application (Proteomics, Drug discovery and Development, Genomics), Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Multiplex Immunosorbent Assay, Immunoprecipitation, Others), End User (Hospitals, Home care settings, Clinical Laboratories, Others) – Industry Trends and Forecast to 2029.
Immunoturbidimetry Reagents Market Analysis and Size
Immunoturbidimetry (IT) is an important diagnostic technique in the broad field of clinical chemistry. It is used to identify serum proteins that are undetectable using traditional clinical chemistry methods and the antigen-antibody reaction. Immunoturbidimetry relies on the specific and sensitive interactions of an antigen and an antibody. Each antibody binds to a different antigen (key and lock).
Data Bridge Market Research analyses that the immunoturbidimetry reagents market which is expected a healthy CAGR of 6.50% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Immunoturbidimetry Reagents Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Kidney Function Test, Diabetes, High Blood Pressure, IVD Test), Application (Proteomics, Drug discovery and Development, Genomics), Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Multiplex Immunosorbent Assay, Immunoprecipitation, Others), End User(Hospitals, Home care settings, Clinical Laboratories, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Siemens Healthcare Private Limited (Germany), Randox Laboratories Ltd. (U.K.), BBI Solutions (U.K.), Abbott (U.S.), FUJIFILM India Private Limited (U.S.), Erba Mannheim (Germany) and Biocompare (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Immunoturbidimetry is an appropriate technique for determining urinary proteins in clinical laboratories. We created immunoturbidimetric assays for measuring urinary albumin and transferrin that are compatible with the Cobas-BIO centrifugal analyzer. The ability of immune-complex precipitates to interact with incident light is quantified using turbidimetry (immunoturbidimetry) and nephelometry (immunonephelometry). The detector is oriented at a straight-on 180-degree angle relative to the incident light source for turbidimetric measurements. Immunoturbidimetry Reagents are available for the estimation of RF, ASO, CRP and Direct HbA1c.
Global Immunoturbidimetry Reagents Market Dynamics
Drivers
- Growing need of IVD testing
The growing demand for IVD testing is driven by rising rates of chronic and infectious diseases, as well as an ageing population prone to immunological disorders. Furthermore, increased use of personalised medicines and increased awareness of rare diseases are propelling the market. Another rise in testing specific proteins for infectious diseases, cardiac diseases, diabetes, autoimmune disorders, inflammatory markers, and other conditions has been observed. These are the certain factors which propel the growth of market.
- Rising cardiovascular diseases
India is experiencing a rapid demographic transition. By 2050, the percentage population of the elderly (aged 60 and up) is expected to increase by about 20%. According to the LASI (The Longitudinal Ageing Study in India) report, the burden of noncommunicable illness is increasing. It is estimated that 45 million people have cardiovascular disease and high blood pressure, 20 million have diabetes, and 24% have difficulty performing daily activities and this factor is propelling the growth of the market.
Opportunities
- Rising number of patients
The rising number of patients suffering from breast autoimmune disorders, cardiac diseases, diabetes, infectious diseases, and inflammatory markers is expected to have a significant impact on the immunoturbidimetry reagents market from 2022 to 2029. On the other hand, the growing patient population will create additional opportunities for the immunoturbidimetry reagents market during the forecast period.
Restraints/Challenges
- High consumables cost
High consumables costs and need of trained and experienced personal will hamper the growth of the immunoturbidimetry reagents will obstruct the market's growth rate.
High consumable costs necessitate highly trained person. Immunoturbidimetric tests are performed on routine biochemistry analyzers, which are versatile, fast, and cost-effective, with longer reagent stability. The primary benefit of nephelometry was its sensitivity; however, latex-enhanced immunoturbidimetry has closed this gap.
This immunoturbidimetry reagents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunoturbidimetry reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Immunoturbidimetry Reagents Market Scope
The immunoturbidimetry reagents market is segmented on the basis of indication, application, technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Kidney Function Test
- Diabetes
- High Blood Pressure
- IVD Test
Application
- Proteomics
- Drug discovery and Development
- Genomics
Technology
- Western Blot
- Immunofluorescence
- Immunohistochemistry
- Flow Cytometry
- Enzyme-linked Immunosorbent Assay
- Multiplex Immunosorbent Assay
- Immunoprecipitation
- Others
End User
- Hospitals
- Home care settings
- Clinical Laboratories
- Others
Immunoturbidimetry Reagents Market Regional Analysis/Insights
The immunoturbidimetry reagents market is analysed and market size insights and trends are provided by country, indication, application, technology and end user as referenced above.
The countries covered in the immunoturbidimetry reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the immunoturbidimetry reagents market due to the high prevalence of local players in the market, rise in the adoption of targeted immunotherapy.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising awareness amongst people regarding diabetes and high blood pressure-related conditions.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Immunoturbidimetry Reagents Market Share Analysis
The immunoturbidimetry reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to immunoturbidimetry reagents market.
Some of the major players operating in the immunoturbidimetry reagents market are:
- Siemens Healthcare Private Limited (Germany)
- Randox Laboratories Ltd. (U.K.)
- BBI Solutions (U.K.)
- Abbott (U.S.)
- FUJIFILM India Private Limited (U.S.)
- Erba Mannheim (Germany)
- Biocompare (U.S.)
SKU-